Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT06021444
Other study ID # DKM-420-MD-1
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date December 30, 2020
Est. completion date July 18, 2023

Study information

Verified date August 2023
Source Dongkook Pharmaceutical Co., Ltd.
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

To prove the non-inferiority of DKM420 by evaluating the injecting efficacy and safety DKM 420 and control for patients who have osteoarthritis of Knee.


Description:

A multi-center, randomized, double-blind, active-controlled, pivotal, non-inferiority clinical study


Recruitment information / eligibility

Status Completed
Enrollment 250
Est. completion date July 18, 2023
Est. primary completion date June 1, 2023
Accepts healthy volunteers No
Gender All
Age group 40 Years to 80 Years
Eligibility Inclusion Criteria: - Men and Women who is over 40 under 80 ages. - Diagnosed as osteoarthritis of Knee and satisfies the 3 of 6 ACR(American College of Rheumatology) conditions. - Kellgren Lawrence grade (?~?) at Visit 1 or within 24 weeks. - 100mm VAS(Visual Analogue Scale) over 40mm. - Etc. Exclusion Criteria: - Pregnancy and lactating women

Study Design


Intervention

Device:
DKM420
A total of 3 doses will be applied at a dose of 2 mL over 3 weeks.
Conjuran
A total of 3 doses will be applied at a dose of 2 mL over 3 weeks.

Locations

Country Name City State
Korea, Republic of chung-Ang University Hospital Seoul

Sponsors (1)

Lead Sponsor Collaborator
Dongkook Pharmaceutical Co., Ltd.

Country where clinical trial is conducted

Korea, Republic of, 

Outcome

Type Measure Description Time frame Safety issue
Primary 100mm VAS(Visual Analogue Scale) Change(The minimum value is 0mm, the maximum value is 100m, the lower the better.) 16 weeks
Secondary 100mm VAS(Visual Analogue Scale) Change(The minimum value is 0mm, the maximum value is 100m, the lower the better.) 2, 8 weeks
Secondary K-WOMAC(Korean Western Ontario and McMaster Universities) Change(Score from 0 to 96, the lower the better.) 2, 8, 16 weeks
See also
  Status Clinical Trial Phase
Not yet recruiting NCT03274713 - Efficacy of Electro-acupuncture Versus Manual Acupuncture on Knee Osteoarthritis N/A
Completed NCT04535596 - Blood Flow Restriction Exercises and Conservative Exercises in Knee Osteoarthritis N/A
Completed NCT03918291 - Whole-body Vibration Training on Functional Performance of the Elderly With Knee Osteoarthritis N/A
Recruiting NCT06263517 - Clinical Trial to Assess Efficacy, Tolerability of Rising Doses of Clodronate in Painful Knee Osteoarthritis Patients Phase 2/Phase 3
Completed NCT01453738 - Allogeneic Mesenchymal Stem Cells in Osteoarthritis Phase 2
Active, not recruiting NCT01027819 - Comparison of Outcomes in Mobile and Fixed-bearing Total Knee Arthroplasty Phase 4
Completed NCT01186211 - Feasibility of Outpatient Total Knee Arthroplasty
Active, not recruiting NCT00261066 - Outcome Following Orthopaedic Surgery
Completed NCT03484910 - Biofeedback With Cycling Exercise in OA Knee Patients N/A
Recruiting NCT03884374 - Pain Relief for OsteoArthritis Through Combined Treatment (PROACT) N/A
Completed NCT03492320 - Progression of Health Related Quality of Life of Patients Waiting for Total Knee Arthroplasty
Completed NCT01449552 - Temporary Clamping of Drains Combined With Tranexamic Acid Reduce Blood Loss After TKA: A Prospective RCT N/A
Completed NCT06254976 - Serum Nesfatin-1 and Human Cartilage Glycoprotein-39 Levels in Knee Osteoarthritis N/A
Completed NCT03428893 - Mobile Technology to Support Physical Therapy Exercise N/A
Completed NCT05081921 - Clinical Trial to Evaluate Safety and Efficacy of MesoCellA-Ortho Tissue-Engineered Advanced Therapy Product in Patients With Osteoarthrosis and Civilisation Diseases Phase 1/Phase 2
Completed NCT02850068 - Geniculate Artery Embolization for the Treatment of Knee Pain N/A
Active, not recruiting NCT03110172 - Short-term Efficacy of Antidepressant in Patients Underwent TKA Phase 1/Phase 2
Enrolling by invitation NCT02623660 - Microcurrent Stimulation Reduces Post-Operative Swelling and Healing Time Following Knee Replacement Surgery N/A
Completed NCT02579174 - Total Knee Replacement Component Alignment Using Manual Versus Custom Instrumentation N/A
Completed NCT00790985 - Efficacy of Flavocoxid 500 mg Compared With Naproxen 500 mg in Subjects With Moderate-severe Osteoarthritis of the Knee N/A